Galanin Receptors (GALR1, GALR2, and GALR3) Immunoexpression in Enteric Plexuses of Colorectal Cancer Patients: Correlation with the Clinico-Pathological Parameters

Galanin (GAL) is an important neurotransmitter released by the enteric nervous system (ENS) neurons located in the muscularis externa and submucosa enteric plexuses that acts by binding to GAL receptors 1, 2 and 3 (GALR1, 2 and 3). In our previous studies, the GAL immunoexpression was compared in colorectal cancer (CRC) tissue and the adjacent parts of the large intestine wall including myenteric and submucosal plexuses. Recently we have also found that expression levels of GALR1 and GALR3 proteins are elevated in CRC tissue as compared with their expression in epithelial cells of unchanged mucosa. Moreover, higher GALR3 immunoreactivity in CRC cells correlated with better prognosis of CRC patients. To understand the distribution of GALRs in enteric plexuses distal and close to CRC invasion, in the present study we decided to evaluate GALRs expression within the myenteric and submucosal plexuses located proximally and distally to the cancer invasion and correlated the GALRs expression levels with the clinico-pathological data of CRC patients. The immunohistochemical and immunofluorescent methods showed only slightly decreased immunoexpression of GALR1 and GALR3 in myenteric plexuses close to cancer but did not reveal any correlation in the immunoexpression of all three GAL receptors in myenteric plexuses and tumour progression. No significant changes were found between the expression levels of GALRs in submucosal plexuses distal and close to the tumour. However, elevated GALR1 expression in submucosal plexuses in vicinity of CRC correlated with poor prognosis, higher tumour grading and shorter overall survival. When myenteric plexuses undergo morphological and functional alterations characteristic for atrophy, GALRs maintain or only slightly decrease their expression status. In contrast, the correlation between high expression of GALR1 in the submucosal plexuses and overall survival of CRC patients suggest that GAL and GALRs can act as a components of local neuro-paracrine pro-proliferative pathways accelerating the invasion and metastasis of cancer cell. The obtained results suggest an important role of GALR1 in submucosal plexuses function during the progression of CRC and imply that GALR1 expression in submucosal plexuses of ENS could be an important predictive factor for CRC progression.

[1]  R. Coveñas,et al.  The Galaninergic System: A Target for Cancer Treatment , 2022, Cancers.

[2]  R. Hamoudi,et al.  Evaluation of Galanin Expression in Colorectal Cancer: An Immunohistochemical and Transcriptomic Study , 2022, Frontiers in Oncology.

[3]  Z. Kmieć,et al.  Galanin Receptors (GalR1, GalR2, and GalR3) Expression in Colorectal Cancer Tissue and Correlations to the Overall Survival and Poor Prognosis of CRC Patients , 2022, International journal of molecular sciences.

[4]  P. Marcos,et al.  Neuropeptidergic Control of Feeding: Focus on the Galanin Family of Peptides , 2021, International journal of molecular sciences.

[5]  M. Heimesaat,et al.  Galanin receptor 3 attenuates inflammation and influences the gut microbiota in an experimental murine colitis model , 2021, Scientific reports.

[6]  J. Całka,et al.  Review: Occurrence and Distribution of Galanin in the Physiological and Inflammatory States in the Mammalian Gastrointestinal Tract , 2021, Frontiers in Immunology.

[7]  B. Kamińska,et al.  Relative abundance of chemerin mRNA transcript and protein in pituitaries of pigs during the estrous cycle and early pregnancy and associations with LH and FSH secretion during the estrous cycle. , 2020, Animal reproduction science.

[8]  S. Gonkowski,et al.  Mycotoxins and the Enteric Nervous System , 2020, Toxins.

[9]  Z. Kmieć,et al.  Colorectal Cancer Invasion and Atrophy of the Enteric Nervous System: Potential Feedback and Impact on Cancer Progression , 2020, International journal of molecular sciences.

[10]  D. Demsie,et al.  Galanin Receptors as Drug Target for Novel Antidepressants: Review , 2020, Biologics : targets & therapy.

[11]  S. Weis,et al.  Galanin System in Human Glioma and Pituitary Adenoma , 2020, Frontiers in Endocrinology.

[12]  B. Kofler,et al.  Galanin is a potent modulator of cytokine and chemokine expression in human macrophages , 2019, Scientific Reports.

[13]  Y. Zhang,et al.  Galanin receptor 1 plays an antinociceptive effect via inhibiting PKA activation in the nucleus accumbens of rats with neuropathic pain. , 2019, Physiological research.

[14]  T. Carey,et al.  Promoter methylation of galanin receptors as epigenetic biomarkers for head and neck squamous cell carcinomas , 2019, Expert review of molecular diagnostics.

[15]  K. Yoon,et al.  Galanin is an epigenetically silenced tumor suppressor gene in gastric cancer cells , 2018, PloS one.

[16]  V. Klenerova,et al.  The galanin and galanin receptor subtypes, its regulatory role in the biological and pathological functions. , 2017, Physiological research.

[17]  Z. Mei,et al.  Galanin suppresses proliferation of human U251 and T98G glioma cells via its subtype 1 receptor , 2017, Biological chemistry.

[18]  Z. Kmieć,et al.  Expression of the EP300, TP53 and BAX genes in colorectal cancer: Correlations with clinicopathological parameters and survival. , 2017, Oncology reports.

[19]  C. Streba,et al.  B2 adrenergic receptors and morphological changes of the enteric nervous system in colorectal adenocarcinoma , 2017, World journal of gastroenterology.

[20]  Z. Kmieć,et al.  Colorectal cancer patients exhibit increased levels of galanin in serum and colon tissues , 2016, Oncology letters.

[21]  Z. Kmieć,et al.  Myenteric plexuses atrophy in the vicinity of colorectal cancer tissue is not caused by apoptosis or necrosis. , 2015, Folia histochemica et cytobiologica.

[22]  A. Imai,et al.  Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer , 2016, Clinical & Experimental Metastasis.

[23]  A. Trost,et al.  Distribution of galanin receptors in the human eye. , 2015, Experimental eye research.

[24]  T. Hökfelt,et al.  Physiology, Signaling, and Pharmacology of Galanin Peptides and Receptors: Three Decades of Emerging Diversity , 2015, Pharmacological Reviews.

[25]  S. Kuhara,et al.  Galanin plays an important role in cancer invasiveness and is associated with poor prognosis in stage II colorectal cancer , 2014, Oncology reports.

[26]  Takayuki Uehara,et al.  Galanin receptor 2 utilizes distinct signaling pathways to suppress cell proliferation and induce apoptosis in HNSCC. , 2014, Molecular medicine reports.

[27]  Hyun-Jung Cho,et al.  The enteric nervous system and gastrointestinal innervation: integrated local and central control. , 2014, Advances in experimental medicine and biology.

[28]  Puthen V. Jithesh,et al.  Identification of Galanin and Its Receptor GalR1 as Novel Determinants of Resistance to Chemotherapy and Potential Biomarkers in Colorectal Cancer , 2012, Clinical Cancer Research.

[29]  J. Godlewski,et al.  Characteristic of galaninergic components of the enteric nervous system in the cancer invasion of human large intestine. , 2012, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[30]  E. Mufson,et al.  Endogenous galanin protects mouse hippocampal neurons against amyloid toxicity in vitro via activation of galanin receptor-2. , 2011, Journal of Alzheimer's disease : JAD.

[31]  N. Kerr,et al.  Galanin acts as a trophic factor to the central and peripheral nervous systems. , 2010, Experientia supplementum.

[32]  T. Hökfelt,et al.  Galanin, galanin receptor subtypes and depression-like behaviour. , 2010, Experientia supplementum.

[33]  Hideaki Shimada,et al.  The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma , 2009, Genes, chromosomes & cancer.

[34]  M. Nam,et al.  Galanin Is Up-Regulated in Colon Adenocarcinoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[35]  B. Kofler,et al.  The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. , 2007, Pharmacology & therapeutics.

[36]  A. Hermann,et al.  Galanin receptor subtype GalR2 mediates apoptosis in SH-SY5Y neuroblastoma cells. , 2004, Endocrinology.

[37]  M. Picciotto,et al.  Galanin receptor 1 gene expression is regulated by cyclic AMP through a CREB‐dependent mechanism , 2001, Journal of neurochemistry.

[38]  K. Hirano,et al.  Mechanisms of galanin‐induced contraction in the rat myometrium , 1998, British journal of pharmacology.

[39]  M. Delvaux,et al.  Intracellular pathways triggered by galanin to induce contraction of pig ileum smooth muscle cells. , 1992, The Journal of physiology.

[40]  J. Furness,et al.  Distribution and actions of galanin and vasoactive intestinal peptide in the human colon , 1990, Neuropeptides.